Navigation Links
Reportlinker Adds Ophthalmology and Optometry Macular Degeneration
Date:11/10/2009

NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Ophthalmology and Optometry Macular Degeneration

http://www.reportlinker.com/p0161962/Ophthalmology-and-Optometry-Macular-Degeneration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Life Science Analytics', Ophthalmology and Optometry Macular Degeneration contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of macular degeneration drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

To order this report:

Ophthalmology and Optometry Macular Degeneration

http://www.reportlinker.com/p0161962/Ophthalmology-and-Optometry-Macular-Degeneration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Global Managed Health Care Services Industry
2. Reportlinker Adds Boosting Immunity Through Digestion: The Relation Among Probiotics, Prebiotics and Digestive Enzymes
3. Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015
4. Reportlinker Adds The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
5. Reportlinker Adds Novo Nordisk A/S: PharmaVitae Profile
6. Reportlinker Adds World Pharmaceutical Packaging Report
7. Reportlinker Adds Whos Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report
8. Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report
9. Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report
10. Reportlinker Adds Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy? Report
11. Reportlinker Adds Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets) Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... According to ... In an industry filled with chemical-laden beauty products, one company is going against the ... for you: Mad Hippie. The rising star in the green space is proud to ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... has been hired as FluidEdge’s Vice President of Business Intelligence and Informatics, effective ... Wolf has demonstrated success leading teams as a healthcare business and financial strategist ...
(Date:5/25/2016)... FL (PRWEB) , ... May ... ... has received the American Heart Association/American Stroke Association's Get With The Guidelines®-Stroke ... , This achievement, a second for Memorial Healthcare System, recognizes its ...
(Date:5/25/2016)... City, MO (PRWEB) , ... May 25, 2016 , ... ... collegiate, and amateur athletics, The National Center for Drug Free Sport (Drug Free Sport®) ... Free Sport”. This conference, to be held July 12 – 13 in Kansas City, ...
(Date:5/25/2016)... ... 25, 2016 , ... According to an article published April 14th ... effectively fight against common bacteria and protect against surgical site infections. The article explains ... repair surgery even safer and could further reduce the risk of surgery related ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- According to Kalorama Information, the world market for ... these are challenging times in the market, there ... companies that remain optimistic and seek innovation.  Toward ... medical device companies spend a higher percentage of ... do companies in other industries.  Also, in addition ...
(Date:5/25/2016)... 2016 MedDay, a biotechnology company focused ... oral presentation entitled "High doses of biotin in progressive multiple ... given by Professor Ayman Tourbah , Principal Investigator of ... European Academy of Neurology (EAN) in Copenhagen, Denmark ... will take place on Sunday, 29 May 2016 from 14:45 ...
(Date:5/24/2016)... 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der ... ‚ausgezeichneter plus guter , Reinigung ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... Daten von der MORA-Studie der Phase III für ...
Breaking Medicine Technology: